Exact Mass: 482.0005

Exact Mass Matches: 482.0005

Found 9 metabolites which its exact mass value is equals to given mass value 482.0005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-Phosphocytidine 5-diphosphoramidate

3-Phosphocytidine 5-diphosphoramidate

C9H17N4O13P3 (482.0005)


   

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

C16H14F3IN2O4 (481.995)


   

N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

C16H14F3IN2O4 (481.995)


   

PD 0325901

N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide

C16H14F3IN2O4 (481.995)


Mirdametinib (PD0325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. Mirdametinib exhibits a Kiapp of 1 nM against activated MEK1 and MEK2. Mirdametinib suppresses the expression of p-ERK1/2 and induces apoptosis. Mirdametinib has anti-cancer activity for a broad spectrum of human tumor xenografts[1][2][3].

   

Ammonium iron(III) sulfate dodecahydrate

Ammonium iron(III) sulfate dodecahydrate

FeH28NO20S2 (481.9995)


   

bis(3,4-dimethylphenyl)iodanium,hexafluorophosphate

bis(3,4-dimethylphenyl)iodanium,hexafluorophosphate

C16H18F6IP (482.0095)


   

PD0325901

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

C16H14F3IN2O4 (481.995)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Mirdametinib (PD0325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. Mirdametinib exhibits a Kiapp of 1 nM against activated MEK1 and MEK2. Mirdametinib suppresses the expression of p-ERK1/2 and induces apoptosis. Mirdametinib has anti-cancer activity for a broad spectrum of human tumor xenografts[1][2][3].

   

4-O-sulfo-beta-D-galactopyranosyl-(1->4)-3,6-anhydro-2-O-sulfo-D-galactose

4-O-sulfo-beta-D-galactopyranosyl-(1->4)-3,6-anhydro-2-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)


   

3,6-anhydro-2-O-sulfo-alpha-D-galactopyranosyl-(1->3)-4-O-sulfo-D-galactose

3,6-anhydro-2-O-sulfo-alpha-D-galactopyranosyl-(1->3)-4-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)